The USPSTF found good evidence that screening for and treatment of HBP has few major harms. The USPSTF concluded with high certainty that the net benefit of screening for HBP in adults is substantial.15 No clinical trials randomly assigned patients to different rescreening intervals and evaluated clinical outcomes. Many observational studies have followed patients over time to determine how many develop hypertension at intervals of 1 to 5 y.15,164 Clinical Recommendations USPSTF Final Recommendation Statement on HBP in Adults15 The USPSTF recommends screening for HBP in adults aged 18 y or older. The USPSTF recommends obtaining measurements outside of the clinical setting for diagnostic confirmation before starting treatment.164 (USPSTF, Grade A) ABPM indicates ambulatory blood pressure monitoring; BP, blood pressure; CDU, care delivery unit; DBP, diastolic blood pressure; HBP, high blood pressure; HBPM, home blood pressure monitoring; SBP, systolic blood pressure; and USPSTF, US Preventive Services Task Force. 36 Appendix A. Continued SM-4: Use of an EHR to Accurately Diagnose and Assess HBP Control Measure Components The CDU uses an EHR system to obtain data that permit assessment of accurate diagnosis and assessment of HBP control and documentation of ASCVD risk, including: The EHR/registry vendor should be able to export SDP and DBP measurements associated with ambulatory clinic visits, including the date of service. The CDU should consider a standardized field in which the clinician can document the BP used in decision making and the date of service. The CDU should consider a standardized field to record home BP determinations and ASCVD risk assessment. The EHR/registry vendors should consider creating structured data elements using established, standardized nomenclature. Rationale A growing number of health systems are developing or using registries and EHRs that permit large-scale queries to support population health management strategies to identify undiagnosed or undertreated hypertension. 